Figure 5From: Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer NF-κB and Ki67 staining. A) Percent intratumoral NF-κB staining is shown for the indicated treatment groups (n = 5-6 mice/group). B) Percent Ki67-positive intratumoral staining is shown (n = 4 mice/group). Results are presented as the mean +/− SEM. * P < 0.05 vs. placebo.Back to article page